Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nintedanib With or Without Dextromethorphan in Idiopathic Pulmonary Fibrosis (IPF) Patients
NCT07583589Phase 2Not yet recruiting
- Sponsor
- The First Affiliated Hospital of Wenzhou Medical University
- Start
- May 2026
- Primary completion
- Mar 2027
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of dextromethorphan in idiopathic pulmonary fibrosis (IPF), sponsored by The First Affiliated Hospital of Wenzhou Medical University. Planned start May 2026; status: not yet recruiting.
02
Drugs
dextromethorphan
03
Conditions
idiopathic pulmonary fibrosis (IPF)
Beyond the preview
Go deeper on NCT07583589.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07583589.